ASX - By Stock
|
PAA |
Re:
Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
|
|
Banastas
|
167 |
38K |
4 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
167
|
38K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
|
|
Banastas
|
167 |
38K |
6 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
167
|
38K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results
|
|
Banastas
|
86 |
17K |
2 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
86
|
17K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
|
|
Banastas
|
167 |
38K |
4 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
167
|
38K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
|
|
Banastas
|
167 |
38K |
10 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
167
|
38K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
|
|
Banastas
|
167 |
38K |
3 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
167
|
38K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
|
|
Banastas
|
167 |
38K |
5 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
167
|
38K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
|
|
Banastas
|
167 |
38K |
5 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
167
|
38K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
7 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
1.4K
|
378K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
7 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
1.4K
|
378K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
12 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
1.4K
|
378K
|
12
|
|
ASX - By Stock
|
ECS |
Re:
ECS Price Action
|
|
Banastas
|
2.3K |
528K |
4 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
2.3K
|
528K
|
4
|
|
ASX - By Stock
|
ECS |
Re:
ECS news
|
|
Banastas
|
521 |
107K |
3 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
521
|
107K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Media Interest, MIPS COVID-19 Vaccine & Sterile Readiness
|
|
Banastas
|
170 |
43K |
4 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
170
|
43K
|
4
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Response to ASX Price Query
|
|
Banastas
|
100 |
22K |
0 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
100
|
22K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Response to ASX Price Query
|
|
Banastas
|
100 |
22K |
0 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
100
|
22K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Response to ASX Price Query
|
|
Banastas
|
100 |
22K |
0 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
100
|
22K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Banastas
|
197 |
35K |
9 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
197
|
35K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Banastas
|
197 |
35K |
3 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
197
|
35K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: Change in substantial holding
|
|
Banastas
|
22 |
5.8K |
1 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
22
|
5.8K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints
|
|
Banastas
|
132 |
31K |
13 |
17/07/21 |
17/07/21 |
ASX - By Stock
|
132
|
31K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
Banastas
|
732 |
147K |
4 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
732
|
147K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust and WEHI to Investigate HTLV-1 Viral Infections
|
|
Banastas
|
42 |
11K |
7 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
42
|
11K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust and WEHI to Investigate HTLV-1 Viral Infections
|
|
Banastas
|
42 |
11K |
8 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
42
|
11K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust and WEHI to Investigate HTLV-1 Viral Infections
|
|
Banastas
|
42 |
11K |
8 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
42
|
11K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints
|
|
Banastas
|
132 |
31K |
6 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
132
|
31K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives ethics approval for Phase I trial in MND
|
|
Banastas
|
67 |
15K |
11 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
67
|
15K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
Banastas
|
273 |
68K |
9 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
273
|
68K
|
9
|
|
ASX - By Stock
|
IDT |
Re:
Ann: COVID-19 Vaccine Manufacture discussions with VicGov & MIPS
|
|
Banastas
|
84 |
19K |
4 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
84
|
19K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
Banastas
|
273 |
68K |
3 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
273
|
68K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
IDT media thread
|
|
Banastas
|
759 |
221K |
0 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
759
|
221K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
Banastas
|
273 |
68K |
5 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
273
|
68K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
Banastas
|
273 |
68K |
7 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
273
|
68K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
Banastas
|
273 |
68K |
6 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
273
|
68K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
Banastas
|
273 |
68K |
5 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
273
|
68K
|
5
|
|
ASX - By Stock
|
IDT |
Re:
IDT media thread
|
|
Banastas
|
759 |
221K |
4 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
759
|
221K
|
4
|
|
ASX - By Stock
|
IDT |
Re:
IDT media thread
|
|
Banastas
|
759 |
221K |
2 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
759
|
221K
|
2
|
|
ASX - By Stock
|
IDT |
Re:
IDT media thread
|
|
Banastas
|
759 |
221K |
2 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
759
|
221K
|
2
|
|
ASX - By Stock
|
IDT |
Re:
IDT media thread
|
|
Banastas
|
759 |
221K |
1 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
759
|
221K
|
1
|
|
ASX - By Stock
|
IDT |
Re:
IDT Australia - Showing signs of life?
|
|
Banastas
|
13 |
3.5K |
0 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
13
|
3.5K
|
0
|
|
ASX - By Stock
|
IDT |
Re:
IDT Australia - Showing signs of life?
|
|
Banastas
|
13 |
3.5K |
1 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Creso Pharma completes US OTC dual listing
|
|
Banastas
|
226 |
62K |
5 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
226
|
62K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives ethics approval for Phase I trial in MND
|
|
Banastas
|
67 |
15K |
7 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
67
|
15K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives ethics approval for Phase I trial in MND
|
|
Banastas
|
67 |
15K |
5 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
67
|
15K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives ethics approval for Phase I trial in MND
|
|
Banastas
|
67 |
15K |
12 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
67
|
15K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
Banastas
|
732 |
147K |
8 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
732
|
147K
|
8
|
|
ASX - By Stock
|
SWP |
Re:
Twiggy own 20%
|
|
Banastas
|
20 |
12K |
0 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
20
|
12K
|
0
|
|
ASX - By Stock
|
SWP |
Re:
Twiggy own 20%
|
|
Banastas
|
20 |
12K |
1 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
20
|
12K
|
1
|
|
ASX - By Stock
|
SWP |
Re:
Twiggy own 20%
|
|
Banastas
|
20 |
12K |
0 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
20
|
12K
|
0
|
|
ASX - By Stock
|
AUA |
Re:
Ann: Revenue and Sales Update
|
|
Banastas
|
5 |
2.0K |
3 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
5
|
2.0K
|
3
|
|